Pharma-Bio Serv (PBSV) Other financing activities (2021 - 2024)

Pharma-Bio Serv (PBSV) has reported Other financing activities for 4 consecutive years, with $1.0 the latest figure, recorded in Q1 2024.

• For the quarter ending Q1 2024, Other financing activities changed N/A year-over-year to $1.0; the trailing twelve-month figure through Apr 2024 stood at $6.0 (down 25.0% YoY), and the FY2023 full-year result was $5.0, up 66.67% from the prior year.
• Other financing activities fell to $1.0 in Q1 2024 per PBSV's latest filing, from $5.0 in the prior quarter.
• Across five years, Other financing activities topped out at $5.0 in Q2 2023 and bottomed at $1.0 in Q1 2024.
• Historically, Other financing activities has averaged $2.75 across 4 years, with a median of $2.5 in 2021.
• The widest YoY moves for Other financing activities: up 50.0% in 2022, down 50.0% in 2022.
• Over 4 years, Other financing activities stood at $2.0 in 2021, then soared by 50.0% to $3.0 in 2022, then surged by 66.67% to $5.0 in 2023, then sank by 80.0% to $1.0 in 2024.
• According to Business Quant data, Other financing activities over the past three periods registered $1.0, $5.0, and $3.0 for Q1 2024, Q2 2023, and Q1 2022 respectively.